As consumer awareness and regulatory scrutiny intensify, baby and infant product manufacturers face growing litigation over alleged trace contaminants such as PFAS, lead, benzene, and microplastics.

Join Baby Safety Alliance Associate Member Greenberg Traurig, LLP on Tuesday, October 6, 2026 at 2 p.m. ET for Emerging Litigation Risks in Baby Products: Trace Contaminant Claims at the Intersection of Toxic Torts and Products Liability, a timely discussion of the legal, scientific, and regulatory challenges facing manufacturers of baby and infant products. As consumer awareness and regulatory scrutiny intensify, companies face growing litigation over alleged trace contaminants such as PFAS, lead, benzene, and microplastics. This panel examines how these claims are blurring traditional products liability and toxic tort doctrines, particularly where exposure levels are low, the science continues to develop, and causation remains contested.

Panelists will discuss recent litigation trends, emerging plaintiff theories—including failure to warn, design defect, and consumer fraud—and the challenges courts face in evaluating scientific evidence, dose-response thresholds, and regulatory standards.

The session will also address defense strategies and proactive risk mitigation, including supply-chain management, product testing, and labeling considerations.

Designed for in-house counsel, litigators, and risk professionals, this panel offers practical guidance for navigating a rapidly developing, high-stakes area at the intersection of science, regulation, and litigation.

Speakers:

Sydney Fairchild Williamson | Shareholder | Atlanta

Sydney Fairchild Williamson defends pharmaceutical, medical device, and consumer product manufacturers, as well as other corporate clients, in complex nationwide products liability and mass tort litigation. Sydney is skilled at advising clients on the evolving intersection of products liability and environmental toxic torts, including litigation involving emerging chemical exposures such as ethylene oxide and per- and polyfluoroalkyl substances (PFAS), guiding them through complex scientific, regulatory, and risk-management challenges. She also advises clients on litigation holds, evidence preservation, and regulatory compliance.

Sydney plays an integral role in developing and executing strategic litigation tactics that align courtroom advocacy with her clients’ overarching business objectives. Her practice centers on developing and advancing the company story, particularly in technically complex matters involving scientific, medical, regulatory, operational, or industry-specific issues.

She has substantial experience preparing and presenting company witnesses and developing regulatory and scientific experts. Sydney works closely with in-house legal teams to marshal documents, coordinate resources, and collaborate with experts. She is adept at translating complex regulatory frameworks, scientific data, and technical subject matter into clear, credible, and compelling testimony. By integrating expert analysis into an overarching narrative, she strengthens case strategy from early assessment through trial.

Brady Herman | Shareholder | Atlanta

Brady has experience in all phases of litigation, particularly in bench and jury trials in state and federal courts, having chaired seven jury trials and more than 50 bench trials. He has served as a key team member on more than 10 trial teams in some of the most high-profile civil litigations in the country involving hernia mesh, consumer products, IVC filters, and ethylene oxide. Brady has conducted and defended depositions of expert witnesses, corporate representatives, medical professionals, and fact witnesses, and examined them at trial. He is skilled at crafting detailed case strategies, collaborating with legal teams, and effectively communicating complex information to judges and juries. Brady maintains a robust motions practice and routinely briefs and argues discovery, dispositive, and post-trial motions.

Prior to joining the firm, Brady externed for Chief Justice Thompson of the Georgia Supreme Court. He subsequently transitioned into private practice, where he defended institutional clients and companies in matters involving complex premises liability, personal injury, wrongful death, commercial litigation, transportation, property disputes, and construction defects. Brady approaches each case with the end in mind, keeping his clients’ goals at the forefront of his litigation strategy.